These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3010696)

  • 21. Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy.
    Ungerleider JT; Andrysiak TA; Fairbanks LA; Tesler AS; Parker RG
    Radiology; 1984 Feb; 150(2):598-9. PubMed ID: 6318262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is THC an effective antiemetic for cancer patients? Opinion 1.
    Frytak S
    CA Cancer J Clin; 1980; 30(5):278-82. PubMed ID: 6250681
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy.
    Friedman CJ; Burris HA; Yocom K; Blackburn LM; Gruben D
    Oncologist; 2000; 5(2):136-43. PubMed ID: 10794804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone in the treatment of nausea and vomiting from cancer chemotherapy.
    Winokur SH; Baker JJ; Lokey JL; Price NA; Bowen J
    J Med Assoc Ga; 1981 Apr; 70(4):263-4. PubMed ID: 7012258
    [No Abstract]   [Full Text] [Related]  

  • 26. Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy.
    Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z
    Oncology; 1989; 46(2):105-8. PubMed ID: 2652018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
    Cunningham D; Forrest GJ; Soukop M; Gilchrist NL; Calder IT; McArdle CS
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):864-5. PubMed ID: 2996690
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
    Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
    Ahmedzai S; Carlyle DL; Calder IT; Moran F
    Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
    Kwong WJ; Parasuraman TV
    Pharm Pract Manag Q; 1999 Apr; 19(1):28-41. PubMed ID: 10351607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
    Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Rosenberg SA
    Cancer; 1981 Apr; 47(7):1746-51. PubMed ID: 6261926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
    Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
    N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of prochlorperazine and lorazepam antiemetic regimens in the control of postchemotherapy symptoms.
    Simms SG; Rhodes VA; Madsen RW
    Nurs Res; 1993; 42(4):234-9. PubMed ID: 8337162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents.
    Braude D; Soliz T; Crandall C; Hendey G; Andrews J; Weichenthal L
    Am J Emerg Med; 2006 Mar; 24(2):177-82. PubMed ID: 16490647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.
    Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Simon RM; Rosenberg SA
    Ann Intern Med; 1979 Dec; 91(6):819-24. PubMed ID: 293141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
    Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
    Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
    Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
    Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
    Yomiya K; Takei D; Kurosawa H; Kono B
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1037-41. PubMed ID: 23986047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
    Bishop JF; Olver IN; Wolf MM; Matthews JP; Long M; Bingham J; Hillcoat BL; Cooper IA
    J Clin Oncol; 1984 Jun; 2(6):691-5. PubMed ID: 6374058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.